National Cancer Institute (NCI) To Spotlight Rehavior’s Health Motivation Identifier (HMI) and JAMA Article: “Effect of Patient-Directed Messaging on Colorectal Cancer Screening A Randomized Clinical Trial” on their website.
We are thrilled to announce that the National Cancer Institute (NCI) has recognized the significance of Rehavior's Health Motivation Identifier (HMI) tool and has requested more information about its capabilities. This acknowledgement by the NCI highlights the growing potential impact of our tool in improving patient communication and outcomes in cancer screening.
In addition, the NCI would like to spotlight our recent JAMA article titled " Effect of Patient-Directed Messaging on Colorectal Cancer Screening A Randomized Clinical Trial" on their website. This article underscores the importance of heightened awareness and effective communication in cancer screening, showcasing the invaluable contribution of our tool. It is a remarkable milestone that extends beyond colon cancer and offers hope to countless individuals affected by this devastating disease.
Understanding the immense burden faced by those affected by cancer, we are committed to providing a glimmer of hope through the utilization of our evidence-based HMI tool. The recognition from the esteemed NCI serves as a testament to the effectiveness and potential of our approach, validating our mission to revolutionize patient communication in the field of cancer screening. By offering a foundation of evidence-based strategies, our tool empowers healthcare professionals to connect with patients on a deeper level, instilling hope throughout their cancer journey.
Being at the forefront of this transformative movement is an honor, fueled by our passion to improve patient outcomes and elevate the standard of cancer care. We remain dedicated to exploring and expanding the application of our tool, with the ultimate goal of positively impacting the lives of individuals affected by cancer.
Together, we can make a difference in the fight against cancer. Stay tuned for further updates as we continue our mission to revolutionize patient communication and contribute to improved cancer screening outcomes.
